Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

TScan Therapeutics, Inc.

NASDAQ: TCRX · Life Sciences · 4 alerts · CIK 1783328

Share price
$0.1451Close, Nov 16
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All TScan Therapeutics, Inc. filings on SEC EDGAR ↗

5:00 PM ET 8-K
Executive Compensation

TScan Therapeutics Executive Compensation

TScan Therapeutics entered into separation agreements with its outgoing CFO, Jason A. Amello, and CMO, Dr. Chrystal Louis, following a strategic reorganization. The agreements provide for continued salary and benefits through November 1, 2026, and include potential milestone-based cash awards of $85,000 and $125,000, respectively, under a 2025 retention program.

Counterparty
Jason A. Amello and Chrystal Louis, M.D., MPH
Term
through Nov 1, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.